Varicella zoster virus (VZV) pneumonia is associated with significant mortality, especially in the immunocompromised host. VZV-specific immunoglobulins (VZIG) are currently used as post-exposure prophylaxis for at-risk patients, but not as adjunctive therapy. A novel case of VZV pneumonia in an immunocompromised patient, treated successfully with intravenous VZIG in combination with acyclovir, is reported here.
Adjuvant treatment of severe varicella pneumonia with intravenous varicella zoster virus-specific immunoglobulins / D. Mangioni, G. Grasselli, C. Abbruzzese, A. Muscatello, A. Gori, A. Bandera. - In: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. - ISSN 1201-9712. - 85(2019 Aug), pp. 70-73.
Titolo: | Adjuvant treatment of severe varicella pneumonia with intravenous varicella zoster virus-specific immunoglobulins |
Autori: | GRASSELLI, GIACOMO (Secondo) GORI, ANDREA (Penultimo) BANDERA, ALESSANDRA (Ultimo) |
Parole Chiave: | Immunocompromised host; Intensive care unit; Intravenous immunoglobulins; Pneumonia; Varicella zoster virus |
Settore Scientifico Disciplinare: | Settore MED/41 - Anestesiologia Settore MED/17 - Malattie Infettive |
Data di pubblicazione: | ago-2019 |
Rivista: | |
Tipologia: | Article (author) |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1016/j.ijid.2019.05.022 |
Appare nelle tipologie: | 01 - Articolo su periodico |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
Mangioni_intJinfdis_1-s2.0-S1201971219302292-main.pdf | Publisher's version/PDF | Open Access Visualizza/Apri |